Related Experiment Video
Updated: Aug 10, 2026

Thermal Imaging to Study Stress Non-invasively in Unrestrained Birds
Published on: November 6, 2015
Studies on the mechanisms of glucocorticoid hypertension in humans
1Department of Medicine, St. George Hospital, University of New South Wales, Kogarah, Australia.
Insights
Glucocorticoid-induced hypertension, common in Cushing's syndrome and steroid use, does not stem from sodium retention. Instead, increased pressor responsiveness may drive elevated blood pressure in these conditions.
Area of Science:
- Endocrinology
- Cardiovascular Medicine
- Pharmacology
Background:
- Hypertension is a significant complication of Cushing's syndrome and exogenous steroid administration.
- Cardiovascular risks are elevated in patients with glucocorticoid-induced hypertension.
- The underlying mechanisms of this hypertension are not fully understood.
Purpose of the Study:
- To investigate the mechanisms of glucocorticoid-induced hypertension.
- To determine if sodium retention or volume expansion contributes to elevated blood pressure.
- To explore the role of pressor responsiveness in glucocorticoid hypertension.
Main Methods:
- Review of existing literature on glucocorticoid-induced hypertension.
- Analysis of patient data from studies on Cushing's syndrome and iatrogenic steroid use.
- Assessment of physiological parameters related to blood pressure regulation.
Main Results:
- Glucocorticoid-induced hypertension is not associated with significant urinary sodium retention.
- Volume expansion does not appear to be the primary driver of hypertension.
- Increased pressor responsiveness to vasoconstrictors is implicated as a key factor.
Conclusions:
- The mechanism of glucocorticoid-induced hypertension in humans is complex and multifactorial.
- Elevated pressor responsiveness is a likely contributor to hypertension in these conditions.
- Further research is needed to fully elucidate the pathophysiology and guide therapeutic strategies.
Abstract:
Hypertension is a common feature of both Cushing's syndrome, which is relatively rare, and iatrogenic steroid administration, which is much more common. Cardiovascular mortality and morbidity are very significant in patients with both naturally occurring and iatrogenic disease. The mechanism of glucocorticoid induced hypertension in man remains undefined. Contrary to previous notions, it does not reflect urinary sodium retention or volume expansion. Increased pressor responsiveness may be an important contributor to the rise in blood pressure.
Related Concept Videos
Hypertension and Regulation of Blood Pressure
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Cushing Syndrome I: Introduction
Cushing Syndrome II: Pathophysiology

